Rhythm Pharmaceuticals (RYTM) EBT Margin (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) reported EBT Margin of 91.65% for Q1 2026, up 5945.0% year-over-year from 1.52% in Q1 2025, and down 10.39% on a QoQ basis from 83.03% in Q4 2025.
Rhythm Pharmaceuticals (RYTM) has 6 years of EBT Margin data on file, last reported at 91.65% in Q1 2026.
- Quarterly EBT Margin rose 5945.0% year-over-year to 91.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 92.89% (up 3028.0% YoY) and the FY2025 annual result came in at 103.31%, up 9669.0% from the prior year.
- EBT Margin retreated to 91.65% in Q1 2026 per RYTM's latest filing, from 83.03% in the prior quarter.
- Across five years, EBT Margin topped out at 527.99% in Q4 2022 and bottomed at 3506.74% in Q1 2022.
- The 5-year median for EBT Margin is 151.11% (2025), against an average of 406.1%.
- Peak annual rise in EBT Margin reached 1425364 bps in 2022, while the deepest fall reached 19138103 bps in 2022.
- Tracing RYTM's EBT Margin over 5 years: stood at 527.99% in 2022, then tumbled by 132 bps to 170.99% in 2023, then soared by 39 bps to 103.71% in 2024, then rose by 20 bps to 83.03% in 2025, then slipped by 10 bps to 91.65% in 2026.
- Per Business Quant, the three latest RYTM EBT Margin figures stand at 91.65% (Q1 2026), 83.03% (Q4 2025), and 102.91% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Rhythm Pharmaceuticals | 6.00 Bn | 5.66 Bn | 52.96 Mn | -91.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.65% |
| Dec 31, 2025 | -83.03% |
| Sep 30, 2025 | -102.91% |
| Jun 30, 2025 | -95.45% |
| Mar 31, 2025 | -151.11% |
| Dec 31, 2024 | -103.71% |
| Sep 30, 2024 | -132.28% |
| Jun 30, 2024 | -109.30% |
| Mar 31, 2024 | -543.27% |
| Dec 31, 2023 | -170.99% |
| Sep 30, 2023 | -194.61% |
| Jun 30, 2023 | -242.98% |
| Mar 31, 2023 | -454.96% |
| Dec 31, 2022 | 527.99% |
| Sep 30, 2022 | -953.80% |
| Jun 30, 2022 | -494.90% |
| Mar 31, 2022 | -3,506.74% |
| Dec 31, 2021 | -2,798.84% |
| Sep 30, 2021 | -4,290.08% |
| Jun 30, 2021 | -14,748.54% |
| Mar 31, 2021 | 187,874.29% |